A woman wearing a blue shirt talkingVideo | 2:35

A Patient’s Experience with Histotripsy

Read More
Histotripsy diagramVideo | 2:57

Bubbles Have Never Been More Powerful: Histotripsy’s Novel Mechanism of Action in Destroying Targeted Tissues.

Histotripsy is a novel, non-invasive, sonic beam therapy that uses the mechanical forces created by focused ultrasound waves. Histotripsy’s unique mechanism of action results in cellular and sub- cellular destruction that occurs only within the bubble cloud, enabling highly precise treatments and avoiding damage to non-targeted tissue. View this video to understand more about the novel capabilities of HistoSonics Edison system in delivering precision histotripsy to targeted liver tissue.
Read More
Cliff Cho profileVideo | 1:36

How Histotripsy Works

Dr. Cliff Cho, University of Michigan surgical oncologist and histotripsy researcher, describes histotripsy’s unique features and mechanism of action.
Read More
Zhen profileVideo | 2:26

How Ultrasound and Histotripsy Work With Your Body

Zhen Xu PhD., Professor of Biomedical Engineering at the University of Michigan and lead histotripsy researcher, explains how histotripsy mechanically destroys its targets using mechanical forces without heat or ionizing radiation.
Read More
Joan Vidal Jove profileVideo | 3:34

A Surgeon’s Perspective on Histotripsy

Watch Dr. Joan Vidal-Jove explain how he first discovered the potential of histotripsy and his work with the HistoSonics team.
Read More
Zhen profileVideo | 5:24

The Beginning of Histotripsy

Zhen Xu PhD. discusses the origin of histotripsy and the work of the University of Michigan biomedical engineering and clinical research teams.
Read More
Histotripsy, the future of surgeryVideo | 8:24

The Evolution of Histotripsy

The team at the University of Michigan has pioneered the development of histotripsy – a new technique to achieve mechanical fractionation of tissue structure using short, high intensity ultrasound pulses.
Read More

Last published on June 1, 2023

Caution: Federal law (USA) restricts this device to sale by or on the order of a physician.

The Edison® System is intended for the non-invasive mechanical destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors via histotripsy. The FDA has not evaluated the Edison System for the treatment of any disease including, but not limited to, cancer or evaluated any specific cancer outcomes (such as local tumor progression, 5-year survival or overall survival). The System should only be used by persons who have completed training performed by HistoSonics, and its use guided by the clinical judgment of an appropriately trained physician. Refer to the device Instructions for Use for a complete list of warnings, precautions and a summary of clinical trial results, including reported adverse events.

Footer last updated on November 8, 2023
X New Twitter Logo
© 2019-2023 HistoSonics®. All rights reserved.